These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34957587)

  • 1. Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants.
    Wu CR; Kim HJ; Sun CP; Chung CY; Lin YY; Tao MH; Kim JH; Chen DS; Chen PJ
    Hepatology; 2022 Jul; 76(1):207-219. PubMed ID: 34957587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
    Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
    Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.
    Ijaz S; Torre F; Tedder RS; Williams R; Naoumov NV
    J Med Virol; 2001 Mar; 63(3):210-6. PubMed ID: 11170059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.
    Karthigesu VD; Allison LM; Ferguson M; Howard CR
    J Med Virol; 1999 Aug; 58(4):346-52. PubMed ID: 10421400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
    Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
    J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.
    Wang W; Sun L; Li T; Ma Y; Li J; Liu Y; Li M; Wang L; Li C; Xie Y; Wen Y; Liang M; Chen L; Tong S
    MAbs; 2016; 8(3):468-77. PubMed ID: 26713590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody.
    Mesenas SJ; Chow WC; Zhao Y; Lim GK; Oon CJ; Ng HS
    J Gastroenterol Hepatol; 2002 Feb; 17(2):148-52. PubMed ID: 11966944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.
    Schreiber S; Dressler LS; Loffredo-Verde E; Asen T; Färber S; Wang W; Groll T; Chakraborty A; Kolbe F; Kreer C; Kosinska AD; Simon S; Urban S; Klein F; Riddell SR; Protzer U
    Front Immunol; 2024; 15():1340619. PubMed ID: 38711498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study.
    Furuta RA; Yasui T; Minamitani T; Akiba H; Toyoda C; Tobita R; Yasui K; Aminaka R; Masaki M; Satake M
    Transfusion; 2023 Jun; 63(6):1204-1214. PubMed ID: 37119513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?
    van Nunen AB; de Man RA; Heijtink RA; Vossen AC; Schalm SW
    J Viral Hepat; 2002 May; 9(3):221-8. PubMed ID: 12010511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of monoclonal antibodies broadly neutralize infection of hepatitis B virus.
    Zhang H; Itoh Y; Suzuki T; Ihara KI; Tanaka T; Haga S; Enatsu H; Yumiya M; Kimura M; Takada A; Itoh D; Shibazaki Y; Nakao S; Yoshio S; Miyakawa K; Miyamoto Y; Sasaki H; Kajita T; Sugiyama M; Mizokami M; Tachibana T; Ryo A; Moriishi K; Miyoshi E; Kanto T; Okamoto T; Matsuura Y
    Microbiol Immunol; 2022 Apr; 66(4):179-192. PubMed ID: 35084739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees.
    Eren R; Ilan E; Nussbaum O; Lubin I; Terkieltaub D; Arazi Y; Ben-Moshe O; Kitchinzky A; Berr S; Gopher J; Zauberman A; Galun E; Shouval D; Daudi N; Eid A; Jurim O; Magnius LO; Hammas B; Reisner Y; Dagan S
    Hepatology; 2000 Sep; 32(3):588-96. PubMed ID: 10960454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody.
    Zankharia US; Kudchodkar S; Khoshnejad M; Perales-Puchalt A; Choi H; Ho M; Zaidi F; Ugen KE; Kim JJ; Weiner DB; Muthumani K
    Hum Vaccin Immunother; 2020 Sep; 16(9):2156-2164. PubMed ID: 32463327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
    Rosenau J; Kreutz T; Kujawa M; Bahr MJ; Rifai K; Hooman N; Finger A; Michel G; Nashan B; Kuse ER; Klempnauer J; Tillmann HL; Manns MP
    J Hepatol; 2007 Apr; 46(4):635-44. PubMed ID: 17316869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
    Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
    Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.